Datasets:
SKT27182
/
NER_processed_data

Dataset card Data Studio Files
xet
Community
1
id
stringlengths
11
11
tags
stringlengths
10
777
text
stringlengths
2
1.5k
dataset_num
int64
1
3
tokens
list
ner_tags
list
NCT02446236
39:95:treatment
Patients who have previously received high-dose chemotherapy with peripheral stem cell support
1
[ "Patients", "who", "have", "previously", "received", "high-dose", "chemotherapy", "with", "peripheral", "stem", "cell", "support" ]
[ 0, 0, 0, 0, 0, 1, 1, 1, 1, 1, 1, 1 ]
NCT02388685
1:12:treatment,16:36:treatment,
angioplasty or lumbar sympathectomy within 3 months of enrollment
1
[ "angioplasty", "or", "lumbar", "sympathectomy", "within", "3", "months", "of", "enrollment" ]
[ 1, 0, 1, 1, 0, 0, 0, 0, 0 ]
NCT01829958
1:26:chronic_disease
Systemic fungal infection
1
[ "Systemic", "fungal", "infection" ]
[ 2, 2, 2 ]
NCT02744430
,,,59:66:treatment
Single unilateral ureteral calculus 4 to 10 mm visible on CT scan within the ureter
1
[ "Single", "unilateral", "ureteral", "calculus", "4", "to", "10", "mm", "visible", "on", "CT", "scan", "within", "the", "ureter" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0 ]
NCT02132598
38:61:treatment,63:86:treatment,91:126:treatment,121:125:treatment,176:193:treatment,
The subject is receiving concomitant treatment with warfarin, warfarin-related agents, or low molecular weight heparin (LMWH) at the time of study entry at therapeutic doses. Low-dose warfarin (≤ 1 mg/day) or LMWH at prophylactic doses
1
[ "The", "subject", "is", "receiving", "concomitant", "treatment", "with", "warfarin", ",", "warfarin-related", "agents", ",", "or", "low", "molecular", "weight", "heparin", "(", "LMWH", ")", "at", "the", "time", "of", "study", "entry", "at", "therapeutic", "doses", ".", "Low-dose", "warfarin", "(", "≤", "1", "mg/day", ")", "or", "LMWH", "at", "prophylactic", "doses" ]
[ 0, 0, 0, 0, 0, 1, 1, 1, 0, 1, 1, 0, 0, 1, 1, 1, 1, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02451553
27:35:treatment,56:77:treatment,147:165:treatment,153:165:treatment
patients who already have OncoPlex or other equivalent gene sequencing assay (eg Foundation One, Perthera, Caris etc) test results available from prior tumor biopsy are eligible to participate, without the needed of a repeat tumor biopsy, but the test results need to be available to the study principal investigator
1
[ "patients", "who", "already", "have", "OncoPlex", "or", "other", "equivalent", "gene", "sequencing", "assay", "(", "eg", "Foundation", "One", ",", "Perthera", ",", "Caris", "etc", ")", "test", "results", "available", "from", "prior", "tumor", "biopsy", "are", "eligible", "to", "participate", ",", "without", "the", "needed", "of", "a", "repeat", "tumor", "biopsy", ",", "but", "the", "test", "results", "need", "to", "be", "available", "to", "the", "study", "principal", "investigator" ]
[ 0, 0, 0, 0, 1, 0, 0, 0, 1, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT00719888
,142:159:treatment
these patients must be discussed with the PI prior to enrollment; patients persistently aplastic for greater than one month since completing last chemotherapy are also eligible with PI approval
1
[ "these", "patients", "must", "be", "discussed", "with", "the", "PI", "prior", "to", "enrollment", ";", "patients", "persistently", "aplastic", "for", "greater", "than", "one", "month", "since", "completing", "last", "chemotherapy", "are", "also", "eligible", "with", "PI", "approval" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0 ]
NCT02452008
31:36:cancer,37:43:treatment,87:96:treatment,118:126:treatment
Patients acceptance to have a tumor biopsy of an accessible lesion at baseline and on treatment if the lesion can be biopsied with acceptable clinical risk (as judged by the investigator)
1
[ "Patients", "acceptance", "to", "have", "a", "tumor", "biopsy", "of", "an", "accessible", "lesion", "at", "baseline", "and", "on", "treatment", "if", "the", "lesion", "can", "be", "biopsied", "with", "acceptable", "clinical", "risk", "(", "as", "judged", "by", "the", "investigator", ")" ]
[ 0, 0, 0, 0, 0, 3, 1, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT01453088
1:38:chronic_disease,
Sensory peripheral neuropathy grade 4 within 14 days of enrollment
1
[ "Sensory", "peripheral", "neuropathy", "grade", "4", "within", "14", "days", "of", "enrollment" ]
[ 2, 2, 2, 2, 2, 0, 0, 0, 0, 0 ]
NCT02269293
11:24:treatment,41:56:cancer,68:80:treatment,82:107:treatment,112:131:treatment,,186:195:treatment
Any other prior therapy directed at the malignant tumor, including chemotherapy, biologic/targeted therapy and immunologic therapy, must be discontinued at least 3 weeks prior to study treatment initiation
1
[ "Any", "other", "prior", "therapy", "directed", "at", "the", "malignant", "tumor", ",", "including", "chemotherapy", ",", "biologic/targeted", "therapy", "and", "immunologic", "therapy", ",", "must", "be", "discontinued", "at", "least", "3", "weeks", "prior", "to", "study", "treatment", "initiation" ]
[ 0, 0, 1, 1, 0, 0, 0, 3, 3, 0, 0, 1, 0, 1, 1, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0 ]
NCT02192398
7:17:treatment,
Takes vitamin B2 > 1.6mg/day during the study
1
[ "Takes", "vitamin", "B2", ">", "1.6mg/day", "during", "the", "study" ]
[ 0, 1, 1, 0, 0, 0, 0, 0 ]
NCT02789228
15:25:chronic_disease
Patients with active HIV
1
[ "Patients", "with", "active", "HIV" ]
[ 0, 0, 2, 2 ]
NCT02334865
17:35:chronic_disease
Must be free of systemic infection
1
[ "Must", "be", "free", "of", "systemic", "infection" ]
[ 0, 0, 0, 0, 2, 2 ]
NCT01419561
1:21:chronic_disease
Altered mental state
1
[ "Altered", "mental", "state" ]
[ 2, 2, 2 ]
NCT03109431
1:4:chronic_disease
HIV-negative (high-risk HIV-negative youth will be invited to participate in another study)
1
[ "HIV-negative", "(", "high-risk", "HIV-negative", "youth", "will", "be", "invited", "to", "participate", "in", "another", "study", ")" ]
[ 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02926729
14:39:treatment,41:51:treatment,56:65:treatment
Eligible for breast conserving surgery, lumpectomy and radiation
1
[ "Eligible", "for", "breast", "conserving", "surgery", ",", "lumpectomy", "and", "radiation" ]
[ 0, 0, 1, 1, 1, 0, 1, 0, 1 ]
NCT03033498
105:113:treatment
Consideration by the investigator for any reason that the subject is an unsuitable candidate to receive ABBV-951
1
[ "Consideration", "by", "the", "investigator", "for", "any", "reason", "that", "the", "subject", "is", "an", "unsuitable", "candidate", "to", "receive", "ABBV-951" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1 ]
NCT03125226
1:10:treatment,,67:86:treatment,67:76:treatment,115:127:treatment
Treatment plan for bladder must include at least 4 weeks of daily radiation treatment (most patients will receive chemotherapy concurrent with radiation, but this is not required for trial enrollment)
1
[ "Treatment", "plan", "for", "bladder", "must", "include", "at", "least", "4", "weeks", "of", "daily", "radiation", "treatment", "(", "most", "patients", "will", "receive", "chemotherapy", "concurrent", "with", "radiation", ",", "but", "this", "is", "not", "required", "for", "trial", "enrollment", ")" ]
[ 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02562430
30:54:treatment,
Patients must have either no antidepressant treatment or stable (for at least 4 weeks prior to screening)
1
[ "Patients", "must", "have", "either", "no", "antidepressant", "treatment", "or", "stable", "(", "for", "at", "least", "4", "weeks", "prior", "to", "screening", ")" ]
[ 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT01841333
21:33:chronic_disease,35:44:chronic_disease,55:64:chronic_disease,89:96:treatment
Active uncontrolled acute fungal, bacterial, or other infection that is unresponsive to therapy at time of study drug dosing
1
[ "Active", "uncontrolled", "acute", "fungal", ",", "bacterial", ",", "or", "other", "infection", "that", "is", "unresponsive", "to", "therapy", "at", "time", "of", "study", "drug", "dosing" ]
[ 0, 0, 2, 2, 0, 2, 0, 0, 0, 2, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0 ]
NCT02512718
12:15:allergy_name,17:21:allergy_name,26:29:allergy_name,30:45:allergy_name
Allergy to egg, fish, or soy/legume products
1
[ "Allergy", "to", "egg", ",", "fish", ",", "or", "soy/legume", "products" ]
[ 0, 0, 4, 0, 4, 0, 0, 4, 4 ]
NCT02901067
27:56:allergy_name
Known contraindication to pharmacologic anticoagulation
1
[ "Known", "contraindication", "to", "pharmacologic", "anticoagulation" ]
[ 0, 0, 0, 4, 4 ]
NCT02910700
7:36:treatment,
other immunosuppressive medications within 14 days of study drug administration
1
[ "other", "immunosuppressive", "medications", "within", "14", "days", "of", "study", "drug", "administration" ]
[ 0, 1, 1, 0, 0, 0, 0, 0, 0, 0 ]
NCT02905578
97:131:treatment
If all of the above are met, the potential participant will receive a 15 gram challenge dose of ascorbate via intravenous infusion. This is the final screening procedure
1
[ "If", "all", "of", "the", "above", "are", "met", ",", "the", "potential", "participant", "will", "receive", "a", "15", "gram", "challenge", "dose", "of", "ascorbate", "via", "intravenous", "infusion", ".", "This", "is", "the", "final", "screening", "procedure" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 1, 1, 0, 0, 0, 0, 0, 0, 0 ]
NCT00929006
,19:35:chronic_disease
For girls without hyperandrogenism: serum (calculated) free testosterone concentration within the Tanner stage-specific reference range and the absence of hirsutism
1
[ "For", "girls", "without", "hyperandrogenism", ":", "serum", "(", "calculated", ")", "free", "testosterone", "concentration", "within", "the", "Tanner", "stage-specific", "reference", "range", "and", "the", "absence", "of", "hirsutism" ]
[ 0, 0, 0, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02606045
20:38:treatment,40:54:treatment,56:63:treatment,65:72:treatment,76:82:treatment
Concomitant use of antiplatelet drugs, anticoagulants, dextran, aspirin or NSAIDs
1
[ "Concomitant", "use", "of", "antiplatelet", "drugs", ",", "anticoagulants", ",", "dextran", ",", "aspirin", "or", "NSAIDs" ]
[ 0, 0, 0, 1, 1, 0, 1, 0, 1, 0, 1, 0, 1 ]
NCT02277613
39:66:chronic_disease
Mechanical complications of the index acute myocardial infarction
1
[ "Mechanical", "complications", "of", "the", "index", "acute", "myocardial", "infarction" ]
[ 0, 0, 0, 0, 0, 2, 2, 2 ]
NCT02324387
1:18:chronic_disease
nodal involvement (N0 - N3)
1
[ "nodal", "involvement", "(", "N0", "-", "N3", ")" ]
[ 2, 2, 0, 0, 0, 0, 0 ]
NCT02872857
1:14:chronic_disease,,
Renal disease as defined by creatinine clearance less than 9 milliliters/min
1
[ "Renal", "disease", "as", "defined", "by", "creatinine", "clearance", "less", "than", "9", "milliliters/min" ]
[ 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02129348
22:29:treatment,76:97:chronic_disease,145:160:chronic_disease
Contraindications to lithium in this study include: resting tremor causing functional impairment, history of falls in the last month, untreated thyroid disease or any abnormal thyroid function test (T3, T4, or TSH)
1
[ "Contraindications", "to", "lithium", "in", "this", "study", "include", ":", "resting", "tremor", "causing", "functional", "impairment", ",", "history", "of", "falls", "in", "the", "last", "month", ",", "untreated", "thyroid", "disease", "or", "any", "abnormal", "thyroid", "function", "test", "(", "T3", ",", "T4", ",", "or", "TSH", ")" ]
[ 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02261519
5:23:chronic_disease,,,,
Any movement disorders with a total score higher than 6 on SAS scale, or more than 2 on any items of the AIMS scale
1
[ "Any", "movement", "disorders", "with", "a", "total", "score", "higher", "than", "6", "on", "SAS", "scale", ",", "or", "more", "than", "2", "on", "any", "items", "of", "the", "AIMS", "scale" ]
[ 0, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT01993719
,,120:129:treatment
Women of child-bearing potential who are pregnant or breastfeeding because of the potentially dangerous effects of the treatment on the fetus or infant
1
[ "Women", "of", "child-bearing", "potential", "who", "are", "pregnant", "or", "breastfeeding", "because", "of", "the", "potentially", "dangerous", "effects", "of", "the", "treatment", "on", "the", "fetus", "or", "infant" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0 ]
NCT01568918
1:19:treatment
Lumbar Laminectomy
1
[ "Lumbar", "Laminectomy" ]
[ 1, 1 ]
NCT01553214
12:34:chronic_disease
History of coronary heart disease
1
[ "History", "of", "coronary", "heart", "disease" ]
[ 0, 0, 2, 2, 2 ]
NCT02515773
1:8:chronic_disease,1:10:chronic_disease,12:22:chronic_disease,56:65:chronic_disease,67:112:chronic_disease,114:134:chronic_disease,194:207:chronic_disease
bipolar I, bipolar II, unspecified bipolar and related disorders, Disruptive Mood Dysregulation Disorder (DMDD), cyclothymic disorder, other specified bipolar and related disorders, as well as mood disorder not otherwise specified (if diagnosed in the past as per DSM-IV)
1
[ "bipolar", "I", ",", "bipolar", "II", ",", "unspecified", "bipolar", "and", "related", "disorders", ",", "Disruptive", "Mood", "Dysregulation", "Disorder", "(", "DMDD", ")", ",", "cyclothymic", "disorder", ",", "other", "specified", "bipolar", "and", "related", "disorders", ",", "as", "well", "as", "mood", "disorder", "not", "otherwise", "specified", "(", "if", "diagnosed", "in", "the", "past", "as", "per", "DSM-IV", ")" ]
[ 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 2, 2, 2, 2, 2, 0, 0, 0, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT00540761
1:25:chronic_disease
congestive heart failure
1
[ "congestive", "heart", "failure" ]
[ 2, 2, 2 ]
NCT02050347
,,141:153:treatment
Sexually active patients must be willing to utilize one of the more effective birth control methods during the study and for 6 months after ATL infusion
1
[ "Sexually", "active", "patients", "must", "be", "willing", "to", "utilize", "one", "of", "the", "more", "effective", "birth", "control", "methods", "during", "the", "study", "and", "for", "6", "months", "after", "ATL", "infusion" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1 ]
NCT02091141
82:90:allergy_name,94:114:allergy_name,118:133:allergy_name
History of severe allergic, anaphylactic, or other hypersensitivity reactions to chimeric or humanized antibodies or fusion proteins
1
[ "History", "of", "severe", "allergic", ",", "anaphylactic", ",", "or", "other", "hypersensitivity", "reactions", "to", "chimeric", "or", "humanized", "antibodies", "or", "fusion", "proteins" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 4, 0, 4, 4, 0, 4, 4 ]
NCT00472329
18:21:chronic_disease
Patients who are HIV positive
1
[ "Patients", "who", "are", "HIV", "positive" ]
[ 0, 0, 0, 2, 0 ]
NCT02236013
13:24:chronic_disease,29:43:chronic_disease
Subject has hypokalemia and hypomagnesemia at Screening (defined as values below institutional lower limit of normal [LLN])
1
[ "Subject", "has", "hypokalemia", "and", "hypomagnesemia", "at", "Screening", "(", "defined", "as", "values", "below", "institutional", "lower", "limit", "of", "normal", "[", "LLN", "]", ")" ]
[ 0, 0, 2, 0, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02143726
15:38:treatment,,
have received prior radiation therapy to index lesions ≥ 28 days prior to registration on this protocol if there has been documented progression by RECIST criteria
1
[ "have", "received", "prior", "radiation", "therapy", "to", "index", "lesions", "≥", "28", "days", "prior", "to", "registration", "on", "this", "protocol", "if", "there", "has", "been", "documented", "progression", "by", "RECIST", "criteria" ]
[ 0, 0, 1, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT00678145
1:10:chronic_disease
Hepatitis
1
[ "Hepatitis" ]
[ 2 ]
NCT02975986
1:9:chronic_disease
diabetes status
1
[ "diabetes", "status" ]
[ 2, 0 ]
NCT01859819
49:74:chronic_disease,94:118:chronic_disease,206:213:treatment
These patients are excluded due to the expected intense immunosuppression, increased risk of opportunistic infections, and higher expected septic death rate in this subgroup of patients with this proposed therapy
1
[ "These", "patients", "are", "excluded", "due", "to", "the", "expected", "intense", "immunosuppression", ",", "increased", "risk", "of", "opportunistic", "infections", ",", "and", "higher", "expected", "septic", "death", "rate", "in", "this", "subgroup", "of", "patients", "with", "this", "proposed", "therapy" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 2, 2, 0, 0, 0, 0, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1 ]
NCT02155699
8:26:chronic_disease
have a psychotic disorder (at study entry) and/or have exhibited serious self-harm behaviors
1
[ "have", "a", "psychotic", "disorder", "(", "at", "study", "entry", ")", "and/or", "have", "exhibited", "serious", "self-harm", "behaviors" ]
[ 0, 0, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02139436
7:27:chronic_disease
other neurological disease
1
[ "other", "neurological", "disease" ]
[ 0, 2, 2 ]
NCT01941316
31:41:chronic_disease,,,
Must not have any significant neuropathy (Grades 3-4, or Grade 2 with pain) within 14 days prior to enrollment
1
[ "Must", "not", "have", "any", "significant", "neuropathy", "(", "Grades", "3-4", ",", "or", "Grade", "2", "with", "pain", ")", "within", "14", "days", "prior", "to", "enrollment" ]
[ 0, 0, 0, 0, 0, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02427841
102:110:chronic_disease
History of allergic reactions attributed to compounds of similar chemical or biologic composition to ABRAXANE or other agents used in the study
1
[ "History", "of", "allergic", "reactions", "attributed", "to", "compounds", "of", "similar", "chemical", "or", "biologic", "composition", "to", "ABRAXANE", "or", "other", "agents", "used", "in", "the", "study" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0, 0, 0, 0, 0 ]
NCT02429830
59:68:treatment
Subject has been informed of the study procedures and the treatment and has signed an informed consent form
1
[ "Subject", "has", "been", "informed", "of", "the", "study", "procedures", "and", "the", "treatment", "and", "has", "signed", "an", "informed", "consent", "form" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0 ]
NCT02826681
8:41:chronic_disease
Active acute or known chronic infections
1
[ "Active", "acute", "or", "known", "chronic", "infections" ]
[ 0, 2, 2, 2, 2, 2 ]
NCT02423863
69:84:chronic_disease
While animal reproductive studies have been negative, the simulated viral infection and anti-proliferative activity of this experimental drug may theoretically affect the developing fetus or nursing infant
1
[ "While", "animal", "reproductive", "studies", "have", "been", "negative", ",", "the", "simulated", "viral", "infection", "and", "anti-proliferative", "activity", "of", "this", "experimental", "drug", "may", "theoretically", "affect", "the", "developing", "fetus", "or", "nursing", "infant" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02477839
,,80:84:treatment
Subject is on a stable (concurrently or sequentially) dosage regimen of 1 to 3 AEDs
1
[ "Subject", "is", "on", "a", "stable", "(", "concurrently", "or", "sequentially", ")", "dosage", "regimen", "of", "1", "to", "3", "AEDs" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1 ]
NCT02535312
1:25:treatment
anti-seizure medications are eligible to participate
1
[ "anti-seizure", "medications", "are", "eligible", "to", "participate" ]
[ 1, 1, 0, 0, 0, 0 ]
NCT02148796
1:38:chronic_disease
primary or secondary immunodeficiency
1
[ "primary", "or", "secondary", "immunodeficiency" ]
[ 2, 2, 2, 2 ]
NCT02030990
13:21:chronic_disease,,
Evidence of glaucoma or an intraocular pressure greater than 22 mm Hg at baseline
1
[ "Evidence", "of", "glaucoma", "or", "an", "intraocular", "pressure", "greater", "than", "22", "mm", "Hg", "at", "baseline" ]
[ 0, 0, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT03100370
4:34:chronic_disease
No neuropsychiatric comorbidities
1
[ "No", "neuropsychiatric", "comorbidities" ]
[ 0, 2, 2 ]
NCT01964859
130:151:chronic_disease,153:170:cancer,172:191:chronic_disease,200:203:chronic_disease,205:214:chronic_disease,216:227:chronic_disease,229:240:chronic_disease
Having a significant medical history that the investigator feels is not safe for study participation (for example, some forms of autoimmune conditions, metastatic cancer, infectious diseases such as HIV, HTLV I/II, Hepatitis B, Hepatitis C)
1
[ "Having", "a", "significant", "medical", "history", "that", "the", "investigator", "feels", "is", "not", "safe", "for", "study", "participation", "(", "for", "example", ",", "some", "forms", "of", "autoimmune", "conditions", ",", "metastatic", "cancer", ",", "infectious", "diseases", "such", "as", "HIV", ",", "HTLV", "I/II", ",", "Hepatitis", "B", ",", "Hepatitis", "C", ")" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 2, 0, 3, 3, 0, 2, 2, 0, 0, 2, 0, 2, 2, 0, 2, 2, 0, 0, 0, 0 ]
NCT00919503
19:36:treatment,
Receiving another experimental drug within 4 weeks of initiation of conditioning (day -6) unless approved by the PI
1
[ "Receiving", "another", "experimental", "drug", "within", "4", "weeks", "of", "initiation", "of", "conditioning", "(", "day", "-6", ")", "unless", "approved", "by", "the", "PI" ]
[ 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02498613
,,53:61:treatment,66:75:treatment,248:257:treatment
Pregnant women are excluded from this study because olaparib and cediranib have the potential for teratogenic or abortifacient effects; due to the fact that there is an unknown but potential risk for adverse events in nursing infants secondary to treatment of the mother with olaparib and cediranib, breastfeeding should be discontinued if the mother is treated with cediranib and olaparib
1
[ "Pregnant", "women", "are", "excluded", "from", "this", "study", "because", "olaparib", "and", "cediranib", "have", "the", "potential", "for", "teratogenic", "or", "abortifacient", "effects", ";", "due", "to", "the", "fact", "that", "there", "is", "an", "unknown", "but", "potential", "risk", "for", "adverse", "events", "in", "nursing", "infants", "secondary", "to", "treatment", "of", "the", "mother", "with", "olaparib", "and", "cediranib", ",", "breastfeeding", "should", "be", "discontinued", "if", "the", "mother", "is", "treated", "with", "cediranib", "and", "olaparib" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02957149
32:56:cancer
Metastatic or locally advanced prostatic adenocarcinoma on preoperative evaluation
1
[ "Metastatic", "or", "locally", "advanced", "prostatic", "adenocarcinoma", "on", "preoperative", "evaluation" ]
[ 0, 0, 0, 0, 3, 3, 0, 0, 0 ]
NCT03181516
8:16:chronic_disease,
Active diarrhea (diarrhea is defined in this study as three or more loose stools per day for two consecutive days)
1
[ "Active", "diarrhea", "(", "diarrhea", "is", "defined", "in", "this", "study", "as", "three", "or", "more", "loose", "stools", "per", "day", "for", "two", "consecutive", "days", ")" ]
[ 0, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02195232
29:50:chronic_disease,
Prior history of documented venous thromboembolic event within the last 2 years
1
[ "Prior", "history", "of", "documented", "venous", "thromboembolic", "event", "within", "the", "last", "2", "years" ]
[ 0, 0, 0, 0, 2, 2, 0, 0, 0, 0, 0, 0 ]
NCT02266745
10:20:chronic_disease
Previous malignancy
1
[ "Previous", "malignancy" ]
[ 0, 2 ]
NCT02738749
9:46:chronic_disease
have an acute or chronic inflammatory illness that might alter white cell mRNA expression
1
[ "have", "an", "acute", "or", "chronic", "inflammatory", "illness", "that", "might", "alter", "white", "cell", "mRNA", "expression" ]
[ 0, 0, 2, 2, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0 ]
NCT01419561
37:62:cancer,67:84:chronic_disease,105:127:chronic_disease
Body cavity effusions not caused by primary effusion lymphoma nor chylous effusions directly related to lymphatic infiltration by KS
1
[ "Body", "cavity", "effusions", "not", "caused", "by", "primary", "effusion", "lymphoma", "nor", "chylous", "effusions", "directly", "related", "to", "lymphatic", "infiltration", "by", "KS" ]
[ 0, 0, 0, 0, 0, 0, 3, 3, 3, 0, 2, 2, 0, 0, 0, 2, 2, 0, 0 ]
NCT02106312
1:7:treatment,15:18:chronic_disease,34:70:treatment,96:111:cancer,123:145:cancer,233:248:cancer,310:315:treatment,363:384:treatment
Biopsy proven MLS (including the reciprocal chromosomal translocation t(12;16)(q13;p11); A the primary sarcoma in case of non-metastatic disease for management is with curative intent (regimen to be chosen = 18 x 2 GY) B in case of oligometastatic patients, the metastasis may also be irradiated to a dose of 36 GY in order to postpone the time interval to next systemic chemotherapy. These patients are usually not operated upon and the total dose may also be reached in 12 times 3 Gy, for convenience purposes (see paragraph 10 for radiobiological considerations)
1
[ "Biopsy", "proven", "MLS", "(", "including", "the", "reciprocal", "chromosomal", "translocation", "t", "(", "12", ";", "16", ")", "(", "q13", ";", "p11", ")", ";", "A", "the", "primary", "sarcoma", "in", "case", "of", "non-metastatic", "disease", "for", "management", "is", "with", "curative", "intent", "(", "regimen", "to", "be", "chosen", "=", "18", "x", "2", "GY", ")", "B", "in", "case", "of", "oligometastatic", "patients", ",", "the", "metastasis", "may", "also", "be", "irradiated", "to", "a", "dose", "of", "36", "GY", "in", "order", "to", "postpone", "the", "time", "interval", "to", "next", "systemic", "chemotherapy", ".", "These", "patients", "are", "usually", "not", "operated", "upon", "and", "the", "total", "dose", "may", "also", "be", "reached", "in", "12", "times", "3", "Gy", ",", "for", "convenience", "purposes", "(", "see", "paragraph", "10", "for", "radiobiological", "considerations", ")" ]
[ 1, 0, 2, 0, 0, 0, 1, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 3, 0, 0, 0, 3, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT03042897
30:42:treatment
Is a candidate for immediate hysterectomy, following evaluation by a physician
1
[ "Is", "a", "candidate", "for", "immediate", "hysterectomy", ",", "following", "evaluation", "by", "a", "physician" ]
[ 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0 ]
NCT02460653
19:43:chronic_disease
Patients who have congenital heart defects
1
[ "Patients", "who", "have", "congenital", "heart", "defects" ]
[ 0, 0, 0, 2, 2, 2 ]
NCT02261857
19:31:treatment
On-going need for CPAP therapy based on polysomnography
1
[ "On-going", "need", "for", "CPAP", "therapy", "based", "on", "polysomnography" ]
[ 0, 0, 0, 1, 1, 0, 0, 0 ]
NCT02544880
52:57:cancer
Surgically resectable, recurrent or second primary HNSCC
1
[ "Surgically", "resectable", ",", "recurrent", "or", "second", "primary", "HNSCC" ]
[ 0, 0, 0, 0, 0, 0, 0, 3 ]
NCT02091999
1:17:chronic_disease,21:34:chronic_disease,41:50:chronic_disease
Active infection or corneal ulcer (e.g. keratitis)
1
[ "Active", "infection", "or", "corneal", "ulcer", "(", "e.g", ".", "keratitis", ")" ]
[ 2, 2, 0, 2, 2, 0, 0, 0, 2, 0 ]
NCT02512926
,,53:72:treatment
Pulse Oximetry measurement ≥ 95% saturation without supplemental oxygen
1
[ "Pulse", "Oximetry", "measurement", "≥", "95", "%", "saturation", "without", "supplemental", "oxygen" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 1, 1 ]
NCT02419560
11:19:cancer
Known CNS lymphoma
1
[ "Known", "CNS", "lymphoma" ]
[ 0, 0, 3 ]
NCT02915744
7:17:cancer,30:43:cancer,,114:127:treatment
Prior malignancy (other than breast cancer) unless diagnosed and definitively treated more than 5 years prior to randomization
1
[ "Prior", "malignancy", "(", "other", "than", "breast", "cancer", ")", "unless", "diagnosed", "and", "definitively", "treated", "more", "than", "5", "years", "prior", "to", "randomization" ]
[ 0, 3, 0, 0, 0, 3, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1 ]
NCT02187848
1:27:chronic_disease
Cardiac conduction defects
1
[ "Cardiac", "conduction", "defects" ]
[ 2, 2, 2 ]
NCT02003222
1:20:treatment
MAINTENANCE THERAPY
1
[ "MAINTENANCE", "THERAPY" ]
[ 1, 1 ]
NCT02225548
31:40:treatment,45:65:chronic_disease,94:109:treatment,111:125:treatment,127:147:treatment,149:159:treatment,161:183:treatment,185:189:treatment,195:242:treatment
unwilling to cease use of any treatment for erectile dysfunction during the study, including oral medication, vacuum devices, constrictive devices, injections, urethral suppositories, gels, any over-the-counter or nonprescription medications, and products purchased via the internet
1
[ "unwilling", "to", "cease", "use", "of", "any", "treatment", "for", "erectile", "dysfunction", "during", "the", "study", ",", "including", "oral", "medication", ",", "vacuum", "devices", ",", "constrictive", "devices", ",", "injections", ",", "urethral", "suppositories", ",", "gels", ",", "any", "over-the-counter", "or", "nonprescription", "medications", ",", "and", "products", "purchased", "via", "the", "internet" ]
[ 0, 0, 0, 0, 0, 0, 1, 0, 2, 2, 0, 0, 0, 0, 0, 1, 1, 0, 1, 1, 0, 1, 1, 0, 1, 0, 1, 1, 0, 1, 0, 0, 1, 1, 1, 1, 0, 0, 0, 0, 0, 0, 0 ]
NCT02536794
1:35:chronic_disease
human immunodeficiency virus (HIV)
1
[ "human", "immunodeficiency", "virus", "(", "HIV", ")" ]
[ 2, 2, 2, 2, 0, 0 ]
NCT02469519
19:34:treatment
Already receiving corticosteroids for another condition
1
[ "Already", "receiving", "corticosteroids", "for", "another", "condition" ]
[ 0, 0, 1, 0, 0, 0 ]
NCT02081404
,,,22:46:chronic_disease
NYHA class III or IV congestive heart failure
1
[ "NYHA", "class", "III", "or", "IV", "congestive", "heart", "failure" ]
[ 0, 0, 0, 0, 0, 2, 2, 2 ]
NCT02524275
23:67:cancer,143:150:treatment,158:175:treatment,208:226:cancer
Histologically proven squamous cell carcinoma of the head and neck with measurable disease that is either recurrent after attempted cure with surgery and/or radiation therapy or newly diagnosed disease with distant metastases or incurable at diagnosis
1
[ "Histologically", "proven", "squamous", "cell", "carcinoma", "of", "the", "head", "and", "neck", "with", "measurable", "disease", "that", "is", "either", "recurrent", "after", "attempted", "cure", "with", "surgery", "and/or", "radiation", "therapy", "or", "newly", "diagnosed", "disease", "with", "distant", "metastases", "or", "incurable", "at", "diagnosis" ]
[ 0, 0, 3, 3, 3, 3, 3, 3, 3, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 1, 0, 0, 0, 0, 0, 3, 3, 0, 0, 0, 0 ]
NCT02152956
20:37:chronic_disease
resolved childhood atopic dermatitis
1
[ "resolved", "childhood", "atopic", "dermatitis" ]
[ 0, 0, 2, 2 ]
NCT02320292
19:31:treatment
No indication for chemotherapy
1
[ "No", "indication", "for", "chemotherapy" ]
[ 0, 0, 0, 1 ]
NCT03153982
1:15:cancer
Primary tumors of any head and neck (oral cavity, oropharynx, hypopharynx, or larynx) site will be included
1
[ "Primary", "tumors", "of", "any", "head", "and", "neck", "(", "oral", "cavity", ",", "oropharynx", ",", "hypopharynx", ",", "or", "larynx", ")", "site", "will", "be", "included" ]
[ 3, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02451423
82:90:allergy_name,94:114:allergy_name,118:133:allergy_name
History of severe allergic, anaphylactic, or other hypersensitivity reactions to chimeric or humanized antibodies or fusion proteins
1
[ "History", "of", "severe", "allergic", ",", "anaphylactic", ",", "or", "other", "hypersensitivity", "reactions", "to", "chimeric", "or", "humanized", "antibodies", "or", "fusion", "proteins" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 4, 0, 4, 4, 0, 4, 4 ]
NCT02574728
1:23:chronic_disease
Uncontrolled infection
1
[ "Uncontrolled", "infection" ]
[ 2, 2 ]
NCT01737502
41:52:cancer,54:62:cancer,64:90:cancer,94:116:cancer
Histologic or cytologic confirmation of lung cancer (squamous, ras-mutated adenocarcinoma or small cell lung cancer)
1
[ "Histologic", "or", "cytologic", "confirmation", "of", "lung", "cancer", "(", "squamous", ",", "ras-mutated", "adenocarcinoma", "or", "small", "cell", "lung", "cancer", ")" ]
[ 0, 0, 0, 0, 0, 3, 3, 0, 3, 0, 3, 3, 0, 3, 3, 3, 3, 0 ]
NCT02519348
58:67:treatment,73:82:treatment,103:106:treatment
Have either progressed on, are intolerant to, or refused treatment with sorafenib or another approved TKI
1
[ "Have", "either", "progressed", "on", ",", "are", "intolerant", "to", ",", "or", "refused", "treatment", "with", "sorafenib", "or", "another", "approved", "TKI" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 0, 0, 1 ]
NCT02152956
7:44:cancer
Known central nervous system (CNS) leukemia
1
[ "Known", "central", "nervous", "system", "(", "CNS", ")", "leukemia" ]
[ 0, 3, 3, 3, 3, 3, 0, 0 ]
NCT02565407
25:49:treatment,56:75:treatment,84:109:treatment
Is currently taking any pro-epileptic medication (e.g. epileptogenic drugs such as tricyclic antidepressants)
1
[ "Is", "currently", "taking", "any", "pro-epileptic", "medication", "(", "e.g", ".", "epileptogenic", "drugs", "such", "as", "tricyclic", "antidepressants", ")" ]
[ 0, 0, 0, 0, 1, 1, 0, 0, 0, 1, 1, 0, 0, 1, 1, 0 ]
NCT00368355
22:37:chronic_disease,,,,
Patients with severe hepatic disease (direct bilirubin greater than 3 ug/dl or SGPT (serum glutamic-pyruvic transaminase) greater than 500 ug/dl)
1
[ "Patients", "with", "severe", "hepatic", "disease", "(", "direct", "bilirubin", "greater", "than", "3", "ug/dl", "or", "SGPT", "(", "serum", "glutamic-pyruvic", "transaminase", ")", "greater", "than", "500", "ug/dl", ")" ]
[ 0, 0, 0, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02656706
,,122:131:treatment
must agree to use adequate barrier birth control measures during the course of the study and up to 2 months after end of treatment
1
[ "must", "agree", "to", "use", "adequate", "barrier", "birth", "control", "measures", "during", "the", "course", "of", "the", "study", "and", "up", "to", "2", "months", "after", "end", "of", "treatment" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1 ]
NCT03159936
1:17:treatment,
Systemic therapy is allowed if on a stable dose and using for at least 3 months -background therapies outlined in Protocol
1
[ "Systemic", "therapy", "is", "allowed", "if", "on", "a", "stable", "dose", "and", "using", "for", "at", "least", "3", "months", "-background", "therapies", "outlined", "in", "Protocol" ]
[ 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02360579
1:44:treatment
Intrauterine hormone-releasing system (IUS)
1
[ "Intrauterine", "hormone-releasing", "system", "(", "IUS", ")" ]
[ 1, 1, 1, 1, 0, 0 ]
NCT03023449
16:36:chronic_disease
History of any neurological disease
1
[ "History", "of", "any", "neurological", "disease" ]
[ 0, 0, 0, 2, 2 ]
NCT02140554
26:66:chronic_disease,68:73:chronic_disease,78:83:chronic_disease,86:109:chronic_disease,114:131:chronic_disease
Positive for presence of human immunodeficiency virus type 1 or 2 (HIV-1 and HIV-2), hepatitis B virus (HBV), or hepatitis C (HCV)
1
[ "Positive", "for", "presence", "of", "human", "immunodeficiency", "virus", "type", "1", "or", "2", "(", "HIV-1", "and", "HIV-2", ")", ",", "hepatitis", "B", "virus", "(", "HBV", ")", ",", "or", "hepatitis", "C", "(", "HCV", ")" ]
[ 0, 0, 0, 0, 2, 2, 2, 2, 2, 2, 2, 0, 2, 0, 2, 0, 0, 2, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT03181126
,73:85:treatment
Refractory is defined as persistent disease after at least 2 courses of chemotherapy
1
[ "Refractory", "is", "defined", "as", "persistent", "disease", "after", "at", "least", "2", "courses", "of", "chemotherapy" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1 ]
NCT02013492
35:63:treatment
Patients may not be receiving any other investigational agents
1
[ "Patients", "may", "not", "be", "receiving", "any", "other", "investigational", "agents" ]
[ 0, 0, 0, 0, 0, 0, 1, 1, 1 ]
NCT02622984
14:31:treatment
Currently in alcohol treatment
1
[ "Currently", "in", "alcohol", "treatment" ]
[ 0, 0, 1, 1 ]
NCT03141359
16:26:cancer,
Prior invasive malignancy unless disease free for a minimum of 3 years from enrollment
1
[ "Prior", "invasive", "malignancy", "unless", "disease", "free", "for", "a", "minimum", "of", "3", "years", "from", "enrollment" ]
[ 0, 0, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]